List of Authors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
List of Authors
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Chuck Reed, B.Sc/MS
Bruce Babbitt
Keith Bader
Steven W. Baertschi, PhD
Steven W. Baertschi
Tomasz Baginski
Matthew N. Bahr
Bornadata Bain
Paul Bainbridge
Katherine A. Bakeev
C. Baker
Denyse D. Baker
Arvindh Balakrishnan
Jagdish Balasubramaniam
Mark L. Balboni
Frederick J. Balboni, Jr.
Kenneth Ball
Phil Ball
Karen Balwinski
Rosa Balzan Sarolli
Christine Banaszek
Susan Banbury
Arvind K. Bansal
Sam Barclay
Barry Bardo
Nilesh S. Barhate
David Barker
Scott Barnhart
Michel Baron
Paul W. Barone
Antonello Barresi
Michael D. Barron
Ian Barylski
Hal Baseman
Steve Bates
Ravinderjit Batta
Maurizio Battistini
Matt Bauer
Wolfgang Bauer
Robert Baum
Thomas Baxter
Dr. David Beach
David Beach
Lauren E. Beach
David Beale
James Beall
Mark Beauchamp
Jan Bebber
Melanie Beck
Jeff Becker
NSF Becker
President Becker
Shawn C. Becker
Ulrich Becker
Detlef Beckers
Nick Beckett
Beckloff Associates, Inc.
James W. Bedford
Frank Kofi Bedu-Addo, PhD
Tim Bee
Timothy Bee
Marcus Behrens
Xiaochong Bei
Kevin Beirne
Raffi Bekeredjian
Dennis Bell
Paola Belloni
Brett M. Belongia, PhD
Patrick Bennett
Patty Benson
Marco Benvenuti
Nancy Berg
Hellen Berger
Dr, Alexander Bergmann
Dr. Alexander Bergmann
James Bergum
James S. Bergum, PhD
Cory Berkland
Steven A. Berkowitz
Harold W. Bernthal
Anthony Berry
Mark Berry
Steve Berry
Holly Bertrand
Guia Bertuzzi
Don Berwick, MD
David Besemer
Gabriele Betz
Dipankar Bhadra
Sulekha Bhadra
Hiren Bhagat
R. Bhaskar
Balkrishen Bhat
Meenakshi Bhatia
Nailesh A. Bhatt
Debadeep Bhattacharya
Richard Bhella
Nirmala Bhogal
Hemant Bhutani
Nattamai Bhuvanesh
Back to Top

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here